Pakistan has its second wild poliovirus type 1 case of the year, 4 countries report rising mpox, and the WHO has new resources.
Emergent has received a 10-year BARDA contract worth up to $704 million for advanced development and supply of a monoclonal antibody.
The phase 1 trial will enroll 36 healthy adults at two US clinical sites.
The Sabin Vaccine Institute has been awarded a multiyear contract to advance the development and production of vaccine candidates.
After Uganda declares its Ebola outbreak over, the CDC lifts screening for inbound travelers from the country.
The outbreak was announced on Sep 20, 2022, and involved 142 confirmed cases and a 39% case-fatality rate.
All 3 Zaire Ebola vaccine strategies in 4 African nations prompted an antibody response at 14 days that persisted for a year.
The country has received 1,200 doses of a candidate Sudan Ebola vaccine from the WHO.
The latest case is the stillborn baby of a mother who survived Ebola.
The infection lifts the country's total to 141 lab-confirmed cases, 55 of them fatal.
